STOCK TITAN

Indivior (INDV) director receives 6,518 RSU grant, holding rises to 16,042 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Humphreys Keith reported acquisition or exercise transactions in this Form 4 filing.

Indivior Pharmaceuticals, Inc. director Keith Humphreys reported a compensation-related equity grant. He received 6,518 shares of Common Stock in the form of Restricted Stock Units, with no cash price per share shown in the filing. After this award, he directly holds 16,042 shares of the company’s stock. The RSUs vest on the day immediately before the next annual stockholder meeting following the grant date, as long as he continues serving the company until that vesting date.

Positive

  • None.

Negative

  • None.
Insider Humphreys Keith
Role null
Type Security Shares Price Value
Grant/Award Common Stock 6,518 $0.00 --
Holdings After Transaction: Common Stock — 16,042 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 6,518 shares Restricted Stock Units awarded to director on May 13, 2026
Post-grant holdings 16,042 shares Total common stock directly held after transaction
Transaction date May 13, 2026 Grant/award acquisition of RSUs to director
Restricted Stock Units (RSUs) financial
"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
vesting financial
"The RSUs vest on the day immediately preceding the date of the annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of the Issuer's stockholders financial
"day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Humphreys Keith

(Last)(First)(Middle)
10710 MIDLOTHIAN TURNPIKE
SUITE 125

(Street)
NORTH CHESTERFIELD VIRGINIA 23235

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/13/2026A6,518(1)A$016,042D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.
Remarks:
/s/Alice Givens, Power of Attorney05/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Indivior (INDV) report for Keith Humphreys?

Indivior reported that director Keith Humphreys received a grant of 6,518 Restricted Stock Units. The award represents a contingent right to receive common shares as part of his compensation and is not an open-market purchase or sale.

How many Indivior (INDV) shares does Keith Humphreys hold after this Form 4?

After the reported grant, Keith Humphreys holds 16,042 shares of Indivior common stock. This figure reflects his direct ownership position following the 6,518-share Restricted Stock Unit award disclosed in the Form 4 filing.

What are the vesting terms for the Indivior (INDV) RSUs granted to Keith Humphreys?

The RSUs granted to Keith Humphreys vest on the day immediately before the annual stockholder meeting following the grant date. Vesting is conditioned on his continued service to Indivior through that vesting date, according to the filing footnote.

Does the Keith Humphreys Form 4 for Indivior (INDV) involve a stock sale?

The Form 4 does not report any stock sale by Keith Humphreys. It shows an acquisition coded as a grant or award (transaction code A), reflecting compensation in Restricted Stock Units instead of an open-market transaction.

What type of security was granted to Keith Humphreys by Indivior (INDV)?

Keith Humphreys received Restricted Stock Units tied to Indivior’s common stock. Each RSU represents a contingent right to one share of common stock, subject to vesting conditions based on service through the specified date.